Kayne Anderson Rudnick Investment Management
IRMD icon

Kayne Anderson Rudnick Investment Management’s iRadimed IRMD Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9M Buy
396,982
+47,666
+14% +$4.34M 0.12% 139
2026
Q1 		$33.6M Buy
349,316
+16,087
+5% +$1.61M 0.1% 149
2025
Q4 		$32.4M Buy
+333,229
New +$28.6M 0.09% 158

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's IRMD Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management increased its iRadimed (IRMD) stake by 14% in Q2 2026, buying an estimated $4.34M and bringing the position to 396,982 shares worth $37.9M. The position accounts for 0.12% of the portfolio, ranked #139.

Kayne Anderson Rudnick Investment Management first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 396,982 shares of iRadimed worth $37.9M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management bought 47,666 iRadimed shares in Q2 2026, an estimated $4.34M.
  • iRadimed made up 0.12% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #139 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.